OPKO Health (OPK) Reports Positive Top Line Results from Rayaldee Phase 3 Trial

August 11, 2014 4:31 PM

OPKO Health, Inc. (NYSE: OPK), announced successful top-line results from the first pivotal phase 3 trial of Rayaldee™. This trial ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found